These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 32035928)

  • 1. Canagliflozin ameliorates obesity by improving mitochondrial function and fatty acid oxidation via PPARα in vivo and in vitro.
    Wei D; Liao L; Wang H; Zhang W; Wang T; Xu Z
    Life Sci; 2020 Apr; 247():117414. PubMed ID: 32035928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diabetes medication canagliflozin promotes mitochondrial remodelling of adipocyte via the AMPK-Sirt1-Pgc-1α signalling pathway.
    Yang X; Liu Q; Li Y; Tang Q; Wu T; Chen L; Pu S; Zhao Y; Zhang G; Huang C; Zhang J; Zhang Z; Huang Y; Zou M; Shi X; Jiang W; Wang R; He J
    Adipocyte; 2020 Dec; 9(1):484-494. PubMed ID: 32835596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Korean traditional medicine gyeongshingangjeehwan inhibits adipocyte hypertrophy and visceral adipose tissue accumulation by activating PPARalpha actions in rat white adipose tissues.
    Shin SS; Jung YS; Yoon KH; Choi S; Hong Y; Park D; Lee H; Seo BI; Lee HY; Yoon M
    J Ethnopharmacol; 2010 Jan; 127(1):47-54. PubMed ID: 19799979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canagliflozin, a sodium glucose cotransporter 2 inhibitor, attenuates obesity-induced inflammation in the nodose ganglion, hypothalamus, and skeletal muscle of mice.
    Naznin F; Sakoda H; Okada T; Tsubouchi H; Waise TM; Arakawa K; Nakazato M
    Eur J Pharmacol; 2017 Jan; 794():37-44. PubMed ID: 27876617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LMO3 reprograms visceral adipocyte metabolism during obesity.
    Wagner G; Fenzl A; Lindroos-Christensen J; Einwallner E; Husa J; Witzeneder N; Rauscher S; Gröger M; Derdak S; Mohr T; Sutterlüty H; Klinglmüller F; Wolkerstorfer S; Fondi M; Hoermann G; Cao L; Wagner O; Kiefer FW; Esterbauer H; Bilban M
    J Mol Med (Berl); 2021 Aug; 99(8):1151-1171. PubMed ID: 34018016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic remodeling in adipocytes promotes ciliary neurotrophic factor-mediated fat loss in obesity.
    Crowe S; Turpin SM; Ke F; Kemp BE; Watt MJ
    Endocrinology; 2008 May; 149(5):2546-56. PubMed ID: 18276754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARα and Sirt1 mediate erythropoietin action in increasing metabolic activity and browning of white adipocytes to protect against obesity and metabolic disorders.
    Wang L; Teng R; Di L; Rogers H; Wu H; Kopp JB; Noguchi CT
    Diabetes; 2013 Dec; 62(12):4122-31. PubMed ID: 23990359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SGLT2 inhibitor canagliflozin reduces visceral adipose tissue in db/db mice by modulating AMPK/KLF4 signaling and regulating mitochondrial dynamics to induce browning.
    Qu J; Tian L; Zhang M; Sun B; Chen L
    Mol Cell Endocrinol; 2024 Oct; 592():112320. PubMed ID: 38964727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined treatment with teneligliptin and canagliflozin additively suppresses high-fat diet-induced body weight gain in mice with modulation of lipid metabolism-related gene expression.
    Kawarasaki S; Sawazaki H; Iijima H; Takahashi H; Nomura W; Inoue K; Kawada T; Goto T
    Eur J Pharmacol; 2023 May; 947():175682. PubMed ID: 36965744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the sodium-glucose co-transporter SGLT2 by canagliflozin ameliorates diet-induced obesity by increasing intra-adipose sympathetic innervation.
    Yang X; Liu Q; Li Y; Ding Y; Zhao Y; Tang Q; Wu T; Chen L; Pu S; Cheng S; Zhang J; Zhang Z; Huang Y; Li R; Zhao Y; Zou M; Shi X; Jiang W; Wang R; He J
    Br J Pharmacol; 2021 Apr; 178(8):1756-1771. PubMed ID: 33480065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Danthron ameliorates obesity and MAFLD through activating the interplay between PPARα/RXRα heterodimer and adiponectin receptor 2.
    Ma C; Wang Z; Xia R; Wei L; Zhang C; Zhang J; Zhao L; Wu H; Kang L; Yang S
    Biomed Pharmacother; 2021 May; 137():111344. PubMed ID: 33581653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytes.
    Goto T; Lee JY; Teraminami A; Kim YI; Hirai S; Uemura T; Inoue H; Takahashi N; Kawada T
    J Lipid Res; 2011 May; 52(5):873-84. PubMed ID: 21324916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canagliflozin Ameliorates Nonalcoholic Fatty Liver Disease by Regulating Lipid Metabolism and Inhibiting Inflammation through Induction of Autophagy.
    Xu Z; Hu W; Wang B; Xu T; Wang J; Wei D
    Yonsei Med J; 2022 Jul; 63(7):619-631. PubMed ID: 35748073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heshouwu (Polygonum multiflorum Thunb.) ethanol extract suppresses pre-adipocytes differentiation in 3T3-L1 cells and adiposity in obese mice.
    Choi RY; Lee HI; Ham JR; Yee ST; Kang KY; Lee MK
    Biomed Pharmacother; 2018 Oct; 106():355-362. PubMed ID: 29966981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Srebp-1c/Fgf21/Pgc-1α Axis Regulated by Leptin Signaling in Adipocytes-Possible Mechanism of Caloric Restriction-Associated Metabolic Remodeling of White Adipose Tissue.
    Kobayashi M; Uta S; Otsubo M; Deguchi Y; Tagawa R; Mizunoe Y; Nakagawa Y; Shimano H; Higami Y
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32664386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Obesity Effects of Soy Leaf via Regulation of Adipogenic Transcription Factors and Fat Oxidation in Diet-Induced Obese Mice and 3T3-L1 Adipocytes.
    Li H; Kang JH; Han JM; Cho MH; Chung YJ; Park KH; Shin DH; Park HY; Choi MS; Jeong TS
    J Med Food; 2015 Aug; 18(8):899-908. PubMed ID: 25826408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoting Effect of α-Tocopherol on Beige Adipocyte Differentiation in 3T3-L1 Cells and Rat White Adipose Tissue.
    Tanaka-Yachi R; Takahashi-Muto C; Adachi K; Tanimura Y; Aoki Y; Koike T; Kiyose C
    J Oleo Sci; 2017; 66(2):171-179. PubMed ID: 28154348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined effect of canagliflozin and exercise training on high-fat diet-fed mice.
    Tanaka K; Takahashi H; Katagiri S; Sasaki K; Ohsugi Y; Watanabe K; Rasadul IMD; Mine K; Nagafuchi S; Iwata T; Eguchi Y; Anzai K
    Am J Physiol Endocrinol Metab; 2020 Apr; 318(4):E492-E503. PubMed ID: 32017594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fenofibrate alleviates NAFLD by enhancing the PPARα/PGC-1α signaling pathway coupling mitochondrial function.
    Wang X; Wang J; Ying C; Xing Y; Su X; Men K
    BMC Pharmacol Toxicol; 2024 Jan; 25(1):7. PubMed ID: 38173037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipocyte-Specific Deletion of Manganese Superoxide Dismutase Protects From Diet-Induced Obesity Through Increased Mitochondrial Uncoupling and Biogenesis.
    Han YH; Buffolo M; Pires KM; Pei S; Scherer PE; Boudina S
    Diabetes; 2016 Sep; 65(9):2639-51. PubMed ID: 27284109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.